BioNTech Cofounders To Step Down. Stock Crumbles.

BioNTech's cofounders have announced their decision to step down from their roles, leading to a substantial decline in the company's stock price. Investors are concerned about potential changes in leadership and the company's future direction. The news has raised questions about BioNTech's ongoing projects, especially in vaccine development. The uncertainty surrounding management changes is contributing to bearish sentiment in the biotechnology sector. Market analysts are watching for further developments that could impact BioNTech's operations and investor confidence.